BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6671713)

  • 1. A study of familial combined hyperlipidemia in 11 families.
    Das SK; Chandra M; Shukla RN; Nityanand S; Agarwal SS
    Indian J Med Res; 1983 Nov; 78():665-9. PubMed ID: 6671713
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined familial hyperlipidemia. Study of a family].
    Ahumada-Ayala M; Lozano-Castañeda O; Rull JA; Valles VE; Wong B
    Rev Invest Clin; 1984; 36(2):141-5. PubMed ID: 6484332
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein pattern.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1986; 113():193-216. PubMed ID: 2941985
    [No Abstract]   [Full Text] [Related]  

  • 4. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
    Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial combined hyperlipidemia. I. Variation in the lipoprotein picture].
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Vnitr Lek; 1986 Sep; 32(9):878-86. PubMed ID: 3765425
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
    Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
    Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
    Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
    Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of blood lipid content in patients with myocardial infarct and their relatives].
    Aslanian NL; Badalian GO; Serebriakova IK; Khudabashian NN; Shukhian VM
    Ter Arkh; 1979; 51(8):33-6. PubMed ID: 228442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined familial hyperlipidemia: genetics, lipidic composition and differences with familial hypertriglyceridemia type IV].
    Delgado M; Torres MA; Bellod P; Rubio MJ; Nuño J; de Oya M
    Med Clin (Barc); 1985 Dec; 85(19):792-7. PubMed ID: 4094500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Familial combined hyperlipidemia].
    de Bruin TW; Dallinga-Thie GM; Erkelens DW
    Ned Tijdschr Geneeskd; 1996 Oct; 140(43):2118-21. PubMed ID: 8965962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of bezafibrate in patients with combined hyperlipidemia].
    Vílchez Joya R; Escobar Jiménez F; Campos MM; Torres E; Orduña R; Cabrera J; Núñez J
    Med Clin (Barc); 1986 Feb; 86(5):190-4. PubMed ID: 3959651
    [No Abstract]   [Full Text] [Related]  

  • 13. Complex segregation analysis of hyperlipidemia in a Seattle sample.
    Williams WR; Lalouel JM
    Hum Hered; 1982; 32(1):24-36. PubMed ID: 7068156
    [No Abstract]   [Full Text] [Related]  

  • 14. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
    Ribalta J; La Ville AE; Heras M; Plana N; Masana L
    Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial combined hyperlipidemia. Part II. Clinical picture.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():243-59. PubMed ID: 2946184
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees.
    Cantor RM; de Bruin T; Kono N; Napier S; van Nas A; Allayee H; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1935-41. PubMed ID: 15308552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?
    van der Vleuten GM; Hijmans A; Heil S; Blom HJ; Stalenhoef AF; de Graaf J
    Am J Med Genet A; 2006 May; 140(9):1010-2. PubMed ID: 16575890
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chylomicronemia induced by cimetidine.
    Iverius PH; Brunzell JD
    Gastroenterology; 1985 Sep; 89(3):664-6. PubMed ID: 4018506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia].
    Sziegoleit W; Wichmann T; Block HU; Taube C; Mest HJ
    Wien Klin Wochenschr; 1991; 103(8):227-31. PubMed ID: 1858388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.